The reason for this finding may be the dynamic nature of PD-L1 expression during the progression of breast cancer [10], as shown in a previous study demonstrating PD-L1 status conversion from negative in the primary tumor (PT) to positive in lung metastasis in 1 of 12 TNBC patients [11]. Here, CD274 is linked to breast cancer.